Federated Hermes Inc. Sells 7,371 Shares of Cabot Corporation $CBT

Federated Hermes Inc. lessened its holdings in Cabot Corporation (NYSE:CBT) by 60.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,788 shares of the specialty chemicals company’s stock after selling 7,371 shares during the period. Federated Hermes Inc.’s holdings in Cabot were worth $364,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. American Century Companies Inc. grew its holdings in shares of Cabot by 11.1% during the 2nd quarter. American Century Companies Inc. now owns 1,664,728 shares of the specialty chemicals company’s stock valued at $124,855,000 after purchasing an additional 166,460 shares during the last quarter. Bank of America Corp DE boosted its position in Cabot by 2.0% in the second quarter. Bank of America Corp DE now owns 1,620,440 shares of the specialty chemicals company’s stock valued at $121,533,000 after buying an additional 31,947 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of Cabot by 1.8% during the second quarter. Geode Capital Management LLC now owns 1,421,934 shares of the specialty chemicals company’s stock worth $106,656,000 after buying an additional 25,717 shares during the last quarter. Sei Investments Co. increased its holdings in shares of Cabot by 3.8% during the second quarter. Sei Investments Co. now owns 985,580 shares of the specialty chemicals company’s stock worth $73,923,000 after buying an additional 36,072 shares in the last quarter. Finally, AQR Capital Management LLC lifted its stake in shares of Cabot by 123.0% in the 2nd quarter. AQR Capital Management LLC now owns 867,946 shares of the specialty chemicals company’s stock valued at $65,096,000 after acquiring an additional 478,702 shares during the last quarter. Institutional investors own 93.18% of the company’s stock.

Cabot Stock Performance

Shares of CBT stock opened at $74.69 on Monday. The stock has a market capitalization of $3.90 billion, a PE ratio of 13.08, a PEG ratio of 3.91 and a beta of 0.88. The business’s 50 day simple moving average is $69.28 and its 200 day simple moving average is $71.61. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.67 and a quick ratio of 1.09. Cabot Corporation has a one year low of $58.33 and a one year high of $89.15.

Cabot (NYSE:CBT) last issued its quarterly earnings results on Tuesday, February 3rd. The specialty chemicals company reported $1.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.40 by $0.13. Cabot had a net margin of 8.62% and a return on equity of 22.82%. The firm had revenue of $849.00 million for the quarter, compared to the consensus estimate of $889.11 million. During the same quarter in the previous year, the company earned $1.76 EPS. The company’s revenue for the quarter was down 11.1% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.000-6.500 EPS. As a group, research analysts forecast that Cabot Corporation will post 7.57 earnings per share for the current year.

Cabot Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 13th. Shareholders of record on Friday, February 27th will be issued a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date is Friday, February 27th. Cabot’s dividend payout ratio (DPR) is presently 31.52%.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on CBT shares. Jefferies Financial Group restated a “buy” rating and set a $85.00 price objective on shares of Cabot in a research report on Wednesday. Mizuho set a $75.00 price target on Cabot and gave the stock a “neutral” rating in a report on Wednesday. UBS Group raised their price objective on shares of Cabot from $74.00 to $81.00 and gave the company a “neutral” rating in a report on Thursday. Zacks Research upgraded shares of Cabot from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 27th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Cabot in a research report on Monday, December 29th. One equities research analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $73.75.

Cabot Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.